| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 |
| filingDate |
2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-201791662-A1 |
| titleOfInvention |
CEBRANOPAD FOR THE TREATMENT FROM PAIN SUBJECTS WITH DISTURBED HEPATIC AND / OR DISTURBED KIDNEY FUNCTION |
| abstract |
The invention relates to cebranopadol or its physiologically acceptable salt for use in the treatment or prevention of pain and / or dependence on opioid drugs in a subject with impaired hepatic and / or renal function. |
| priorityDate |
2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |